Get the latest news, insights, and market updates on CL (Colgate-Palmolive Company). Explore the news page 4 on MyTopStock.com for investor discussions, analysis, and real-time stock performance coverage.
Colgate-Palmolive’s 2030 Plan Tests Growth, Productivity And Valuation Optimism
Colgate-Palmolive (NYSE:CL) has launched a new 2030 Strategic Growth and Productivity Program. The company set out a refreshed corporate strategy centered on innovation, digital capabilities, omnichannel demand generation, and organizational restructuring. The program follows recent resilient results for its core operations, alongside ongoing challenges in its skin health business. For you as an investor, this move is tied to Colgate-Palmolive's role as a global consumer products company... Feb 1, 2026 - $CL
Colgate-Palmolive (CL) Climbs 6% on Upbeat Outlook Despite Headwinds
We recently published 10 Big Names Ending January With Explosive Gains. Colgate-Palmolive Company (NYSE:CL) was one of the top performers on Friday. Colgate-Palmolive rallied for a second day on Friday, jumping 6.10 percent to finish at $90.29 apiece as investors took heart from a cautiously optimistic outlook for 2026 amid a challenging market environment that […] Jan 31, 2026 - $CL
Colgate-Palmolive Q4 Earnings Call Highlights
Colgate-Palmolive (NYSE:CL) executives said the company delivered “stronger-than-expected” fourth-quarter results and ended 2025 with improving momentum, while emphasizing that 2026 will begin under a highly uncertain operating backdrop as the company launches its new 2030 strategy. On the company’ Jan 30, 2026 - $CL
We use cookies and similar technologies to collect and process data such as browsing activity or unique identifiers.
Selecting "Allow All" to help us understand site usage and improve the platform.
Choosing "Essential Cookies Only" enables only the cookies necessary for core site functions, such as staying logged in.
For more information, please see our Privacy Policy.